Description

4-((4-bromophenyl){5-hydroxy-1-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-3-methyl-1H-pyrazol-4-yl}methyl)-1-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-3-methyl-1H-pyrazol-5-ol is a complex heterocyclic organic compound featuring a unique molecular scaffold combining pyrazole, thiazole, and phenol functionalities. This compound is of significant interest in advanced pharmaceutical research and development, particularly as a key intermediate or pharmacophore for novel therapeutic agents. It is primarily utilized by R&D chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical sectors for synthesizing targeted bioactive molecules.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of potential drug candidates, especially those targeting inflammation, cancer, or central nervous system disorders.
• Biochemical Research: Used as a reference standard or probe in enzymatic and receptor-binding studies due to its specific structural motifs.
• Material Science Research: Investigated for the development of novel organic electronic materials or metal-chelating agents given its conjugated system and phenolic groups.
• Agrochemical Development: Explored as a precursor for novel pesticides or herbicides, leveraging its heterocyclic core.
• Academic & Contract Research: Employed in universities and CROs (Contract Research Organizations) for methodological development and discovery chemistry projects.

Basic Information

Item	Details
Product Name	4-((4-bromophenyl){5-hydroxy-1-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-3-methyl-1H-pyrazol-4-yl}methyl)-1-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-3-methyl-1H-pyrazol-5-ol
CAS No.	307339-30-6
Molecular Formula	C31H22BrN5O3S2
Molecular Weight	656.57 g/mol
Synonyms	4-[(4-Bromophenyl){5-hydroxy-1-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-3-methyl-1H-pyrazol-4-yl}methyl]-1-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-3-methyl-1H-pyrazol-5-ol; CAS 307339-30-6; 1H-Pyrazol-5-ol, 4-[(4-bromophenyl)[5-hydroxy-1-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-3-methyl-1H-pyrazol-4-yl]methyl]-1-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-3-methyl-; BPT-Hybrid Pyrazol-Thiazol Derivative
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Every batch is characterized and tested using advanced analytical techniques including HPLC, NMR, and mass spectrometry to ensure identity, purity, and batch-to-batch consistency. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment. We support development under cGMP guidelines where required for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container should be kept in a desiccated environment. For long-term storage, consider storing under an inert atmosphere such as nitrogen or argon.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.